Cargando…
Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits
BACKGROUND: The COVID-19 disease frequently causes neurological symptoms. Critically ill patients often require neurorehabilitation for manifestations like intensive care unit (ICU) acquired weakness or encephalopathy. The outcome of these patients, however, is largely unknown. Here we report the cl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649895/ https://www.ncbi.nlm.nih.gov/pubmed/36388208 http://dx.doi.org/10.3389/fneur.2022.1012685 |
_version_ | 1784827886565326848 |
---|---|
author | Wimmer, Corinna Egger, Marion Bergmann, Jeannine Huge, Volker Müller, Friedemann Jahn, Klaus |
author_facet | Wimmer, Corinna Egger, Marion Bergmann, Jeannine Huge, Volker Müller, Friedemann Jahn, Klaus |
author_sort | Wimmer, Corinna |
collection | PubMed |
description | BACKGROUND: The COVID-19 disease frequently causes neurological symptoms. Critically ill patients often require neurorehabilitation for manifestations like intensive care unit (ICU) acquired weakness or encephalopathy. The outcome of these patients, however, is largely unknown. Here we report the clinical course of critical affected COVID-19 patients from hospital admission to discharge from inpatient neurorehabilitation. METHODS: Prospective cohort study. COVID-19 patients admitted to neurorehabilitation were included based on a laboratory-confirmed SARS-CoV-2 infection. Assessments [modified Rankin Scale (mRS), Barthel-Index, Fatigue-Severity-Scale-7 and health-related quality of life (EQ-5D-5L)] were conducted at admission and before discharge from inpatient care. Data were compared to the preclinical health status. RESULTS: Sixty-one patients (62 ± 13 years, 16 female) were included in the analysis. Most patients had been treated on ICU (n = 58; 57 ± 23 days) and had received invasive ventilation (n = 57; 46 ± 21 days). After discharge from ICU, patients spent on average 57 ± 26 days in neurorehabilitation. The most frequent neurological diagnoses were ICU-acquired weakness (n = 56) and encephalopathy (n = 23). During rehabilitation overall disability improved [mRS median (IQR) 4.0 (1.0) at inclusion and 2.0 (1.0) at discharge]. However, the preclinical health state [mRS 0.0 (0.0)] was not regained (p < 0.001). This was also reflected by the Barthel-Index [preclinical 100.0 (0.0), at inclusion 42.5 (35.0), at discharge 65.0 (7.5); p < 0.001]. Patients had only minor fatigue during inpatient care. Quality of life generally improved but was still low at discharge from hospital. CONCLUSION: Patients with neurological sequelae after critical COVID-19 disease showed substantial deficits at discharge from inpatient care up to 4 months after the initial infection. They were restricted in activities of daily living and had reduced health-related quality of life. All patients needed continued medical support and physical treatment. |
format | Online Article Text |
id | pubmed-9649895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96498952022-11-15 Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits Wimmer, Corinna Egger, Marion Bergmann, Jeannine Huge, Volker Müller, Friedemann Jahn, Klaus Front Neurol Neurology BACKGROUND: The COVID-19 disease frequently causes neurological symptoms. Critically ill patients often require neurorehabilitation for manifestations like intensive care unit (ICU) acquired weakness or encephalopathy. The outcome of these patients, however, is largely unknown. Here we report the clinical course of critical affected COVID-19 patients from hospital admission to discharge from inpatient neurorehabilitation. METHODS: Prospective cohort study. COVID-19 patients admitted to neurorehabilitation were included based on a laboratory-confirmed SARS-CoV-2 infection. Assessments [modified Rankin Scale (mRS), Barthel-Index, Fatigue-Severity-Scale-7 and health-related quality of life (EQ-5D-5L)] were conducted at admission and before discharge from inpatient care. Data were compared to the preclinical health status. RESULTS: Sixty-one patients (62 ± 13 years, 16 female) were included in the analysis. Most patients had been treated on ICU (n = 58; 57 ± 23 days) and had received invasive ventilation (n = 57; 46 ± 21 days). After discharge from ICU, patients spent on average 57 ± 26 days in neurorehabilitation. The most frequent neurological diagnoses were ICU-acquired weakness (n = 56) and encephalopathy (n = 23). During rehabilitation overall disability improved [mRS median (IQR) 4.0 (1.0) at inclusion and 2.0 (1.0) at discharge]. However, the preclinical health state [mRS 0.0 (0.0)] was not regained (p < 0.001). This was also reflected by the Barthel-Index [preclinical 100.0 (0.0), at inclusion 42.5 (35.0), at discharge 65.0 (7.5); p < 0.001]. Patients had only minor fatigue during inpatient care. Quality of life generally improved but was still low at discharge from hospital. CONCLUSION: Patients with neurological sequelae after critical COVID-19 disease showed substantial deficits at discharge from inpatient care up to 4 months after the initial infection. They were restricted in activities of daily living and had reduced health-related quality of life. All patients needed continued medical support and physical treatment. Frontiers Media S.A. 2022-10-28 /pmc/articles/PMC9649895/ /pubmed/36388208 http://dx.doi.org/10.3389/fneur.2022.1012685 Text en Copyright © 2022 Wimmer, Egger, Bergmann, Huge, Müller and Jahn. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Wimmer, Corinna Egger, Marion Bergmann, Jeannine Huge, Volker Müller, Friedemann Jahn, Klaus Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits |
title | Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits |
title_full | Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits |
title_fullStr | Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits |
title_full_unstemmed | Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits |
title_short | Critical COVID-19 disease: Clinical course and rehabilitation of neurological deficits |
title_sort | critical covid-19 disease: clinical course and rehabilitation of neurological deficits |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649895/ https://www.ncbi.nlm.nih.gov/pubmed/36388208 http://dx.doi.org/10.3389/fneur.2022.1012685 |
work_keys_str_mv | AT wimmercorinna criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits AT eggermarion criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits AT bergmannjeannine criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits AT hugevolker criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits AT mullerfriedemann criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits AT jahnklaus criticalcovid19diseaseclinicalcourseandrehabilitationofneurologicaldeficits |